• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Middle East Respiratory Syndrome associated with higher mortality, more severe illness

Shiloh

Editor, Senior Moderator
Source: http://www.eurekalert.org/pub_releases/2016-05/ats-mer050916.php

Public Release: 18-May-2016
Middle East Respiratory Syndrome associated with higher mortality, more severe illness
American Thoracic Society

ATS 2016, SAN FRANCISCO -- Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI), according to investigators involved with the largest study of critically ill patients with MERS. The study was presented at the ATS 2016 International Conference.

Until March 20, 2016, 1690 cases of MERS had been reported to the World Health Organization, with 80 percent of those cases in Saudi Arabia. The reported cases had an overall mortality of 35 percent. The investigators - led by Yaseen Arabi, MD, chairman, Intensive Care Department, and professor, College of Medicine, King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia - embarked on their research because few studies have examined the clinical course of critically ill patients...
 
Back
Top